CN104031040B - The synthetic method of 2-sulfydryl-4-pyridyl thiazole - Google Patents
The synthetic method of 2-sulfydryl-4-pyridyl thiazole Download PDFInfo
- Publication number
- CN104031040B CN104031040B CN201410246198.1A CN201410246198A CN104031040B CN 104031040 B CN104031040 B CN 104031040B CN 201410246198 A CN201410246198 A CN 201410246198A CN 104031040 B CN104031040 B CN 104031040B
- Authority
- CN
- China
- Prior art keywords
- sulfydryl
- grams
- reaction
- pyridyl thiazole
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000010189 synthetic method Methods 0.000 title claims abstract description 10
- CMHWFELWUFCKOF-UHFFFAOYSA-N 4-(1,3-thiazol-2-yl)-1H-pyridine-2-thione Chemical compound SC1=NC=CC(=C1)C=1SC=CN1 CMHWFELWUFCKOF-UHFFFAOYSA-N 0.000 title claims description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 9
- YNNGZCVDIREDDK-UHFFFAOYSA-N aminocarbamodithioic acid Chemical compound NNC(S)=S YNNGZCVDIREDDK-UHFFFAOYSA-N 0.000 claims abstract description 6
- -1 4 pyridyl thiazoles Chemical class 0.000 claims abstract description 4
- 239000012043 crude product Substances 0.000 claims description 12
- 238000010792 warming Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 9
- 125000001246 bromo group Chemical class Br* 0.000 claims description 8
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 150000001649 bromium compounds Chemical group 0.000 abstract description 2
- AJKVQEKCUACUMD-UHFFFAOYSA-N 2-Acetylpyridine Chemical class CC(=O)C1=CC=CC=N1 AJKVQEKCUACUMD-UHFFFAOYSA-N 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- WMQUKDQWMMOHSA-UHFFFAOYSA-N 1-pyridin-4-ylethanone Chemical compound CC(=O)C1=CC=NC=C1 WMQUKDQWMMOHSA-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- DCYNAHFAQKMWDW-UHFFFAOYSA-N azane;carbamodithioic acid Chemical class N.NC(S)=S DCYNAHFAQKMWDW-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- BBFCIBZLAVOLCF-UHFFFAOYSA-N pyridin-1-ium;bromide Chemical compound Br.C1=CC=NC=C1 BBFCIBZLAVOLCF-UHFFFAOYSA-N 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- JQRYUMGHOUYJFW-UHFFFAOYSA-N pyridine;trihydrobromide Chemical compound [Br-].[Br-].[Br-].C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 JQRYUMGHOUYJFW-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 125000004119 disulfanediyl group Chemical group *SS* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410246198.1A CN104031040B (en) | 2014-06-05 | 2014-06-05 | The synthetic method of 2-sulfydryl-4-pyridyl thiazole |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410246198.1A CN104031040B (en) | 2014-06-05 | 2014-06-05 | The synthetic method of 2-sulfydryl-4-pyridyl thiazole |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104031040A CN104031040A (en) | 2014-09-10 |
CN104031040B true CN104031040B (en) | 2016-09-14 |
Family
ID=51462061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410246198.1A Active CN104031040B (en) | 2014-06-05 | 2014-06-05 | The synthetic method of 2-sulfydryl-4-pyridyl thiazole |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104031040B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105566313A (en) * | 2016-03-22 | 2016-05-11 | 陕西思尔生物科技有限公司 | Synthesis method of ceftaroline fosamil intermediate 4-(4'-pyridyl)-1,3-thiazolyl-2-thiol |
CN106632001A (en) * | 2016-12-28 | 2017-05-10 | 山东诚汇双达药业有限公司 | Preparation method of 4-(bromoacetyl) pyridine hydrobromide |
CN107602503A (en) * | 2017-09-22 | 2018-01-19 | 山东金城医药化工有限公司 | The synthetic method of the thiazolyl acetic acid of 2 sulfydryl, 4 methyl 5 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004060362A2 (en) * | 2003-01-02 | 2004-07-22 | Millennium Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
US20050176776A1 (en) * | 2004-02-06 | 2005-08-11 | Coleman Paul J. | Mitotic kinesin inhibitors |
CN102558094A (en) * | 2011-11-30 | 2012-07-11 | 浙江工业大学 | Method for preparing ceftaroline side-chain acid |
WO2013084171A1 (en) * | 2011-12-07 | 2013-06-13 | Ranbaxy Laboratories Limited | Process for preparing ceftaroline salts or hydrates thereof |
-
2014
- 2014-06-05 CN CN201410246198.1A patent/CN104031040B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004060362A2 (en) * | 2003-01-02 | 2004-07-22 | Millennium Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
US20050176776A1 (en) * | 2004-02-06 | 2005-08-11 | Coleman Paul J. | Mitotic kinesin inhibitors |
CN102558094A (en) * | 2011-11-30 | 2012-07-11 | 浙江工业大学 | Method for preparing ceftaroline side-chain acid |
WO2013084171A1 (en) * | 2011-12-07 | 2013-06-13 | Ranbaxy Laboratories Limited | Process for preparing ceftaroline salts or hydrates thereof |
Also Published As
Publication number | Publication date |
---|---|
CN104031040A (en) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102093349B (en) | Method for performing industrialized production on moxifloxacin hydrochloride | |
IL250454B1 (en) | High-purity quinoline derivative and method for manufacturing same | |
CN104031040B (en) | The synthetic method of 2-sulfydryl-4-pyridyl thiazole | |
CN101941969B (en) | Preparation method of moxifloxacin hydrochloride | |
CN105218621B (en) | Dehydroabietic acid benzimidazole Schiff base heterocyclic derivatives with anti-tumor activity and preparation method therefor and application thereof | |
JP6452698B2 (en) | Vancomycin derivatives, production methods and applications thereof | |
CN105837530B (en) | A kind of pleuromutilin derivative and its preparation method and application with piperazine sidechain | |
CN104098548B (en) | A kind of Delafloxacin process for purification | |
CN104086572A (en) | Novel technology for preparing cefotetan by one-pot synthesis method | |
WO2012126147A1 (en) | Purification method of cefmetazole sodium | |
CN104274454B (en) | A kind of anti-medicine resistant Staphylococcus aureus composition of medicine and purposes | |
CN103570750A (en) | Preparation process of biapenem | |
JP2011006389A5 (en) | ||
JP6228210B2 (en) | Method for purifying fluvoxamine free base and method for producing high purity fluvoxamine maleate using the same | |
CN102898441A (en) | Method for synthesizing cefotiam | |
CN105859747A (en) | Cefepime dihydrochloride preparation method suitable for industrial production | |
CN102285999B (en) | Method for preparing cefathiamidine in one-step process | |
CN110642764A (en) | Preparation method of water-soluble florfenicol sodium salt | |
CN105198904A (en) | Preparing method for levofloxacin and ofloxacin | |
CN104031069A (en) | Method for preparing cefquinome sulfate | |
US20140121369A1 (en) | Method for purifying ceftizoxime sodium | |
JP2013529687A5 (en) | ||
EP2601193A1 (en) | Compounds with antibacterial activity against clostridium | |
CN102285986A (en) | Industrialized purification method of moxifloxacin | |
DE2215039A1 (en) | New acyloxyalkyl ester derivatives of penicillin and cephalosporin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Tingjian Inventor after: Song Xijun Inventor after: Liao Guozhi Inventor after: Li Yuedong Inventor after: Ma Haiyan Inventor before: Wang Tingjian Inventor before: Song Xijun Inventor before: Ge Zhengquan Inventor before: Li Yuedong |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160802 Address after: 253100 Shandong Dezhou Plain Economic Development Zone north two Ring Road West first northbound Shandong Yunjia Pharmaceutical Co. Ltd. Applicant after: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Address before: 2350 250101, Pioneer Road, hi tech Zone, Shandong, Ji'nan Applicant before: JINAN CHENGHUISHUANGDA CHEMICAL INDUSTRY Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Synthesis of 2-mercapto-4-pyridyl thiazole Effective date of registration: 20220616 Granted publication date: 20160914 Pledgee: Shandong Pingyuan Rural Commercial Bank Co.,Ltd. Pledgor: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Registration number: Y2022980007784 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230726 Granted publication date: 20160914 Pledgee: Shandong Pingyuan Rural Commercial Bank Co.,Ltd. Pledgor: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Registration number: Y2022980007784 |